Effect of administration of zinc supplementation on lipid profile and uric acid in smokers and non-smokers

Dr. Malik Hassan Mehmood0 个研究点目标入组 75 人开始时间: 2022年4月8日最近更新: 2022年9月12日

适应症

试验速览

暂无简介。

•1)Volunteers age range between 18 to 60 years
•2)Only healthy volunteers were included in control group
•3)Smoker must use 5 cigarettes per day from last 2 years
•4)Participants must not receiving prescribed medication like as lipid lowering agents (fibrins, statins) and uric acid lowering agents (allopurinol) which might interfere with study protocol.
•5)Participants included in experimental group were not having the history of some chronic cardiovascular disease, respiratory disease, diabetes mellitus, hepatic or renal disorder or any other severe disease.

•1)Female volunteers if pregnant, lactating or using contraceptive were excluded from the study.
•2)Smokers under nicotine dependence treatment from last three months were excluded from the study.
•3)Persons with decrease lipid profile, uric acid levels and normal level of plasma zinc were not participating in study.
•4)Participants who were recently consuming supplements in the past three months were excluded from study
•5)Persons with alcohol consumption history were not participated in study.

发起方

Dr. Malik Hassan Mehmood